G. М. Galstyan

532 total citations
57 papers, 236 citations indexed

About

G. М. Galstyan is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, G. М. Galstyan has authored 57 papers receiving a total of 236 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 15 papers in Genetics and 14 papers in Oncology. Recurrent topics in G. М. Galstyan's work include Complement system in diseases (9 papers), Lymphoma Diagnosis and Treatment (9 papers) and Hemophilia Treatment and Research (7 papers). G. М. Galstyan is often cited by papers focused on Complement system in diseases (9 papers), Lymphoma Diagnosis and Treatment (9 papers) and Hemophilia Treatment and Research (7 papers). G. М. Galstyan collaborates with scholars based in Russia, United States and Italy. G. М. Galstyan's co-authors include Sergey Shlyapnikov, Paul Herscu, Д. Н. Проценко, Н. Б. Лазарева, Vladimir Gorodetsky, Е. Н. Паровичникова, Savchenko Vg, И. Л. Давыдкин, Andrey Sudarikov and Larisa A. Kuzmina and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Critical Care Medicine.

In The Last Decade

G. М. Galstyan

41 papers receiving 212 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. М. Galstyan Russia 5 62 44 44 42 41 57 236
Joost C. M. Meijers Netherlands 7 60 1.0× 33 0.8× 134 3.0× 107 2.5× 39 1.0× 8 442
Patricia Davenport United States 12 25 0.4× 25 0.6× 96 2.2× 49 1.2× 40 1.0× 29 367
Lori J. Rosenstein United States 6 22 0.4× 28 0.6× 36 0.8× 30 0.7× 37 0.9× 17 247
Ken Tonai Japan 9 45 0.7× 8 0.2× 19 0.4× 100 2.4× 39 1.0× 25 258
Emilia Parodi Italy 10 25 0.4× 49 1.1× 165 3.8× 18 0.4× 51 1.2× 28 268
Jakob Mühlbacher Austria 9 107 1.7× 9 0.2× 26 0.6× 31 0.7× 120 2.9× 27 294
Mitsutaka Nishimoto Japan 10 120 1.9× 31 0.7× 183 4.2× 56 1.3× 19 0.5× 82 348
Noppacharn Uaprasert Thailand 11 13 0.2× 90 2.0× 159 3.6× 24 0.6× 97 2.4× 50 318
Aude Gibelin France 9 23 0.4× 41 0.9× 10 0.2× 46 1.1× 22 0.5× 28 256
Christi Salgado United States 10 10 0.2× 26 0.6× 28 0.6× 87 2.1× 71 1.7× 14 363

Countries citing papers authored by G. М. Galstyan

Since Specialization
Citations

This map shows the geographic impact of G. М. Galstyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. М. Galstyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. М. Galstyan more than expected).

Fields of papers citing papers by G. М. Galstyan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. М. Galstyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. М. Galstyan. The network helps show where G. М. Galstyan may publish in the future.

Co-authorship network of co-authors of G. М. Galstyan

This figure shows the co-authorship network connecting the top 25 collaborators of G. М. Galstyan. A scholar is included among the top collaborators of G. М. Galstyan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. М. Galstyan. G. М. Galstyan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Galstyan, G. М., et al.. (2023). Congenital thrombotic thrombocytopenic purpura in children. 68(4). 443–455.
3.
4.
Galstyan, G. М., et al.. (2023). Neurological disorders in patients with thrombotic thrombocytopenic purpura. Clinical Medicine (Russian Journal). 101(1). 41–49. 2 indexed citations
5.
Galstyan, G. М., et al.. (2022). Thrombotic thrombocytopenic purpura in pregnancy. Giving birth or not giving birth, that is the question. 67(1). 42–61. 3 indexed citations
6.
7.
8.
Galstyan, G. М., et al.. (2021). Hemostasis Disorders in Patients with De Novo Acute Leukemias. SHILAP Revista de lepidopterología. 14(2). 231–238. 1 indexed citations
9.
Galstyan, G. М., et al.. (2021). Inhibitor of BRAFV600E Mutation as a Treatment Option for Hairy Cell Leukemia With Deep Neutropenia and Infectious Complications. Clinical Lymphoma Myeloma & Leukemia. 21(7). 427–430. 8 indexed citations
10.
Паровичникова, Е. Н., et al.. (2021). Risk-adapted combined therapy with arsenic trioxide and all-trans-retinoic acid for de novo acute promyelocytic leuкaemia. 66(2). 168–191. 1 indexed citations
11.
Shestakova, Marina V., et al.. (2021). Russian association of endocrinologist draft recommendation on insulin biosimilars using. SHILAP Revista de lepidopterología. 3 indexed citations
12.
Biderman, Bella, Svetlana Tsygankova, Е. С. Булыгина, et al.. (2020). First experience of allogeneic haematopoietic stem cell transplantation in patients with mantle cell lymphoma with a mutation in the <i>TP53</i> gene. 65(4). 483–500. 1 indexed citations
13.
14.
Galstyan, G. М., et al.. (2019). PROVISION OF CENTRAL VENOUS ACCESS DURING ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION. 64(4). 396–411. 1 indexed citations
15.
16.
Galstyan, G. М., et al.. (2019). DIFFICULTIES IN DIAGNOSTICS OF ATYPICAL HEMOLYTIC UREMIC SYNDROME IN THE INTENSIVE CARE UNIT. SHILAP Revista de lepidopterología. 16(4). 65–76. 2 indexed citations
17.
Galstyan, G. М., et al.. (2018). Thrombotic and Hemorrhagic Complications in the Treatment of Acute Lymphoblastic Leukemia with L-Asparaginase. Clinical oncohematology. 11(1). 89–99. 2 indexed citations
18.
19.
Galstyan, G. М., et al.. (2011). Nine-year experience in the treatment of patients with diffuse large B-cell lymphosarcoma. SHILAP Revista de lepidopterología. 2 indexed citations
20.
Проценко, Д. Н., et al.. (2011). C1-esterase inhibitor infusion increases survival rates for patients with sepsis*. Critical Care Medicine. 40(3). 770–777. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joost C. M. Meijers Breakdown of academic impact, for papers by Patricia Davenport Breakdown of academic impact, for papers by Lori J. Rosenstein Breakdown of academic impact, for papers by Ken Tonai Breakdown of academic impact, for papers by Emilia Parodi Breakdown of academic impact, for papers by Jakob Mühlbacher Breakdown of academic impact, for papers by Mitsutaka Nishimoto Breakdown of academic impact, for papers by Noppacharn Uaprasert Breakdown of academic impact, for papers by Aude Gibelin Breakdown of academic impact, for papers by Christi Salgado
Rankless by CCL
2026